Marked decrease of cyclosporin absorption caused by coadministration of Cordyceps sinensis in rats

Journal of Food and Drug Analysis

Volumn 13, Issue 3, 2005, Pages 239-243

  Chiang, Hsiu Mei ^a,b   Hou, Yu Chi ^a   Tsai, Shang Yuan ^a   Yang, Shih Ying ^a   Chao, Pei Dawn Lee ^a   Hsiu, Su Lan ^a   Wen, Kuo Ching ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cordyceps sinensis; Cyclosporin; Drug interaction; Pharmacokinetics

Indexed keywords

CORDYCEPS SINENSIS EXTRACT; CYCLOSPORIN; CYCLOSPORIN A;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CALCULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FLUORESCENCE POLARIZATION IMMUNOASSAY; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; STUDENT T TEST;

ANIMALIA; CORDYCEPS; CORDYCEPS SINENSIS;

EID: 28044450865     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Manabe, N., Sugimoto, M., Azuma, Y., Taketomo, N., Yamashita, A., Tsuboi, H., Tsunoo, A., Kinjo, N., Nian, L. H. and Miyamoto, H. 1996. Effect of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism in the mouse. Jpn. J. Pharmacol. 70: 85-88.
2. Zhu, J. S., Halpern, G. M. and Jones, K. 1998. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: Part I. J. Altern. Complement Med. 4: 289-303.
3. Liu, Y. K. and Shen, W. 2003. Inhibitive effect of Cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. World J. Gastroenterol. 9: 529-533.
4. Lo, H. C., Tu, S. T., Lin, K. C. and Lin, S. C. 2004. The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci. 74: 2897-2908.
5. Li, S. P., Su, Z. R., Dong, T. X. and Tsim, K. W. 2001. Antioxidation activity of different types of natural Cordyceps sinensis and cultured Cordyceps mycelia. Phytomedicine 8: 207-212.
6. Li, S. P., Zhao, K. J., Ji, Z. N., Song, Z. H., Dong, T. T., Lo, C. K., Cheung, J. K., Zhu, S. Q. and Tsim, K. W. 2003. A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury. Life Sci. 73: 2503-2513.
7. Yamaguchi, Y., Kagota, S., Nakamura, K., Shinozuka, K. and Kunitomo, M. 2000. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother. Res. 14: 647-649.
8. Chen, Y. J., Shiao, M. S., Lee, S. S. and Wang, S. Y. 1997. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci. 60: 2349-2359.
9. Bok, J. W., Lermer, L., Chilton, J., Klingeman, H. G. and Towers, G. H. 1999. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 51: 891-898.
10. Yang, L. Y., Huang, W. J., Hsieh, H. G. and Lin, C. Y. 2003. H1-A extracted from Cordyceps sinensis suppresses the proliferation of human mesangial cells and promotes apoptosis, probably by inhibiting the tyrosine phosphorylation of Bcl-2 and Bcl-XL. J. Lab. Clin. Med. 141: 74-83.
11. Hsu, C. C., Tsai, S. J., Huang, Y. L. and Huang, B. M. 2003. Regulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesis. FEBS Lett. 543: 140-143.
12. Hsu, C. C., Huang, Y. L., Tsai, S. J., Shen, C. C. and Huang, B. M. 2003. In vivo and in vitro stimulatory effects of Cordyceps sinensis on testosterone production in mouse Leydig cells. Life Sci. 73: 2127-2136.
13. Kuo, Y. C., Tsai, W. J., Shiao, M. S., Chen, C. F. and Lin, Y. C. 1996. Cordyceps sinensis as an immunomodulatory agent. Am. J. Chin. Med. 24: 111-125.
14. Yang, L. Y., Chen, A., Kuo, Y. C. and Lin, C. Y. 1999. Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL Ipr/Ipr mice. J. Lab. Clin. Med. 134: 492-500.
15. Hsu, T. H., Shiao, L. H., Hsieh, C. Y. and Chang, D. M. 2002. A comparison of the chemical composition and bioactive ingredients of the Chinese medicinal mushroom DongChongXiaCao, its counterfeit and mimic, and fermented mycelium of Cordyceps sinensis. Food Chem. 78: 463-469.
16. Manzi, P., Ganbelli, L., Mstvoni, D. and Vivanti, V. 1999. Nutrients in edible mushrooms: an inter-species comparative study. Food Chem. 65: 477-482.
17. Hsu, T. H. 1999. Health benefits of Cordyceps - related species. J. Chin. Soc. Tradit. Vet. Soc. 3: 48-61.
18. Burke, J. F. Jr., Pirsch, J. D., Ramos, E. L., Salomon, D. R., Stablein, D. M., Van Buren, D. H. and West, J. C. 1994. Long - term efficacy and safety of cyclosporine in renal-transplant receipients. N. Engl. J. Med. 331: 358-363.
19. Tredger, J. M., Roberts, N., Sherwood, R., Higgins, G. and Keating, J. 2000. Comparison of five cyclosporin immunoassays with HPLC. Clin. Chem. Lab. Med. 38: 1205-1207.
20. Steimer, W. 1999. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clini. Chem. 45: 371-381.
21. Su, S. F. and Huang, J. D. 1996. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab. Dispos. 24: 142-147.
22. Yang, C. Y., Wang, Y. H., Hou, Y. C., Hsiu S. L. and Chao, P. D. 2003. St. John's wort-cyclosporin interaction in rats and pigs. Mid. Taiwan J. Med. 8: 127-133.
23. Fugh-Berman, A. 2000. Herb-drug interactions. Lancet 355: 134-138.
24. Lundahl, J., Regardh, C. G., Edgar, B. and Johnsson, G. 1997. Effecst of grapefruit juice ingestion-pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur. J. Clin. Pharmacol. 52: 139-145.
25. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I. and Gottesman, M. M., 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39: 361-398.
26. Yumoto, R., Murakami, T., Nakamoto, Y., Hasegawa, R., Nagai, J. and Takano, M., 1999. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther. 289: 149-155.